Evidence map›Paper›PMID 36500862›Full record

ArticleNanomaterials (Basel, Switzerland)2022

Molecular Doping of CVD-Graphene Surfaces by Perfluoroalkyl-Substituted Perylene Diimides Derivatives.

Federico Chianese, Lucrezia Aversa, Roberto Verucchi, Antonio Cassinese

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 67% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Federico ChianeseDipartimento di Fisica, Università Degli Studi di Napoli Federico II, Piazzale Tecchio 80, 80125 Napoli, Italy.
Lucrezia AversaInstitute of Materials for Electronics and Magnetism, CNR-IMEM, FBK Trento Unit, Via alla Cascata 56/C, 38123 Trento, Italy.ORCID 0000-0002-7168-9832
Roberto VerucchiInstitute of Materials for Electronics and Magnetism, CNR-IMEM, FBK Trento Unit, Via alla Cascata 56/C, 38123 Trento, Italy.ORCID 0000-0001-6850-3980
Antonio CassineseDipartimento di Fisica, Università Degli Studi di Napoli Federico II, Piazzale Tecchio 80, 80125 Napoli, Italy.
Institute of Materials for Electronics and Magnetism · ITUniversity of Naples Federico II · IT

Funding

Ministry of Education, Universities and Research ARS01_01158
6 · The paper itself

Abstract

Non-covalent π-π and dipolar interactions with small aromatic molecules have been widely demonstrated to be a valid option to tune graphene work functions without adding extrinsic scattering centers for charge carriers. In this work, we investigated the interaction between a CVD-graphene monolayer and a thermally evaporated sub-monolayer and the following few-layer thin films of similar perylene diimide derivatives: PDI8-CN2 and PDIF-CN2. The molecular influence on the graphene work function was estimated by XPS and UPS analysis and by investigating the surface potentials via scanning Kelvin probe force microscopy. The perfluorinated decoration and the steric interaction in the early stages of the film growth determined a positive work function shift as high as 0.7 eV in the case of PDIF-CN2, with respect to the value of 4.41 eV for the intrinsic graphene. Our results unambiguously highlight the absence of valence band shifts in the UPS analysis, indicating the prevalence of dipolar interactions between the graphene surface and the organic species enhanced by the presence of the fluorine-enriched moieties.

Indexed as

graphenemolecular dopingperyleneSKPFMUPSXPS

Identifiers

PMID36500862
PMCPMC9737924
OpenAlexW4310989764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.